Pfizer Introduction...

Like all pharmaceutical companies in the UK, Pfizer (manufacturers of Genuine Pfizer Viagra available from UKMeds4U.com (along with other medications for treating erectile dysfunction such as Viagra, Levitra and Cialis) operates within a series of regulations which set the standards for advertising and promoting prescription-only medicines. As a member of the Association of British Pharmaceutical Industry (ABPI), Pfizer (manufacturers of Genuine Pfizer Viagra available from UKMeds4U.com (along with other medications for treating erectile dysfunction such as Viagra, Levitra and Cialis) adheres to the ABPI Code of Practice.

Pfizer (manufacturers of Genuine Pfizer Viagra available from UKMeds4U.com (along with other medications for treating erectile dysfunction such as Viagra, Levitra and Cialis) supports the Code, and devotes considerable resources to ensure compliance. These standards moderate the kind of information about prescription-only medicines that Pfizer (manufacturers of Genuine Pfizer Viagra available from UKMeds4U.com (along with other medications for treating erectile dysfunction such as Viagra, Levitra and Cialis) can offer for sale, as well as in all other forms of communication.

This Code of Practice aims to ensure that pharmaceutical companies operate in a responsible, ethical and professional manner. It defines what information pharmaceutical companies can provide to healthcare professionals who may prescribe its medicines to patients, and defines what information about its prescription-only medicines companies like Pfizer (manufacturers of Genuine Pfizer Viagra available from UKMeds4U.com (along with other medications for treating erectile dysfunction such as Viagra, Levitra and Cialis) can offer to members of the public – in advertisements, press announcements, or on web sites such as this one.

The ABPI code is administered by the Prescription Medicines Code of Practice Authority (PMCPA). The Code of Practice has been regularly revised since its inception in 1958 and is drawn up in consultation with the British Medical Association, the Royal Pharmaceutical Society of Great Britain, the Royal College of Nursing and the Medicines and Healthcare products Regulatory Agency.